Sharing Individual Participant Data (IPD) within the Context of the Trial Reporting System (TRS)
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
The Institute of Medicine (IOM) [1], journal editors [2,3], and many others [4][5][6] have called for more widespread, third-party access to the individual participant data (IPD) and associated documentation from clinical trials (i.e., "IPD sharing").Advocates assert that access to trial IPD will help to address well-established flaws in the current system of communicating trial results, including nonpublication, selective reporting, and lack of reproducibility [7].Additional proposed benefits include the ability to reanalyze study data (e.g., validation and/or correction of previously published findings [8]) and to combine data from multiple studies (e.g., IPD-level meta-analyses [9]).Others note the burdens and costs associated with preparing IPD and associated documentation for sharing, the need to ensure participant privacy, and the risk of invalid analyses [10].We do not attempt to replicate the more comprehensive analysis of IPD sharing that was conducted by the recent IOM panel [1].However, we believe that it would be helpful at this pivotal time to consider the implications of IPD sharing within the context of the "trial reporting system" (TRS), which encompasses existing efforts to enhance access to information about trials and their findings and to improve the transparency of the clinical research enterprise (CRE) [11].In this essay, we attempt to add precision to the ongoing discussion by examining the range of information granularity associated with different types of IPD.We then consider IPD sharing within a three-level TRS framework and illustrate the roles of these levels with a case study. Summary Points• The role of individual participant data (IPD) sharing can best be understood as part of an overall three-level trial reporting system (TRS) framework.• Different "types" of IPD, which reflect varying degrees of information granularity, have different potential benefits and harms.• Study 329 of Paxil (paroxetine) in children with depression is used as a case study to highlight the potential value of different components of the TRS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials
Schulz, K. F., Altman, D. G., Moher, D., & for the CONSORT Group (2010) · PLoS Medicine · doi:10.1371/journal.pmed.1000251 · Cited by 2,296
Dissemination and publication of research findings: an updated review of related biases
Song, F., Parekh, Hooper, L., Loke, Y., Ryder, J., Sutton, A., Hing, C., Kwok, C., Pang, C., & Harvey, I. (2010) · Health Technology Assessment · doi:10.3310/hta14080 · Cited by 1,039
KELLER, M. B., RYAN, N. D., STROBER, M., KLEIN, R. G., KUTCHER, S. P., BIRMAHER, B., HAGINO, O. R., KOPLEWICZ, H., CARLSON, G. A., CLARKE, G. N., et al. (2001) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200107000-00010 · Cited by 641 · cited 1×
“The original publication of Study 329 in 2001 implied that the study results showed the safety and efficacy of Paxil in children [18].”
ResultPreparing for Responsible Sharing of Clinical Trial Data
Mello, M. M., Francer, J. K., Wilenzick, M., Teden, P., Bierer, B. E., & Barnes, M. (2013) · New England Journal of Medicine · doi:10.1056/nejmhle1309073 · Cited by 175
Cited by
Naudet, F., Sakarovitch, C., Janiaud, P., Cristea, I., Fanelli, D., Moher, D., & Ioannidis, J. P. A. (2018) · BMJ · doi:10.1136/bmj.k400 · Cited by 227
Bashir, R., Bourgeois, F. T., & Dunn, A. G. (2017) · Systematic Reviews · doi:10.1186/s13643-017-0518-3 · Cited by 47
Tan, A. C., Askie, L. M., Hunter, K. E., Barba, A., Simes, R. J., & Seidler, A. L. (2021) · Research Synthesis Methods · doi:10.1002/jrsm.1500 · Cited by 48
Trialists' intent to share individual participant data as disclosed at ClinicalTrials.gov
Bergeris, A., Tse, T., & Zarin, D. A. (2018) · JAMA · doi:10.1001/jama.2017.20581 · Cited by 34
“No response, median (range), % 21 (1-100) 34 (6-100) 37 (3-100) 20 (1-100) Abbreviation: NIH, National Institutes of Health.”
Self-citationEvidence appraisal: a scoping review, conceptual framework, and research agenda
Goldstein, A., Venker, E., & Weng, C. (2017) · Journal of the American Medical Informatics Association · doi:10.1093/jamia/ocx050 · Cited by 30
Metadata
- Authors
- Zarin, D. A., & Tse, T.
- Venue
- PLOS Medicine
- Publisher
- Public Library of Science (PLoS)
- Published
- 2016-01-19
- Volume
- 13
- Issue
- 1
- Pages
- e1001946
- ISSN
- 1549-1277 (ISSN-L)
- 1549-1676
- OpenAlex
- W2273468966
- Cited by
- 53
- References
- 4
- FWCI
- 18.58
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.